Chemical Compound
(3S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (S)-(-)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid; 9,10-Difluoro-3-(S)-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; Levofloxacin Q-acid; Levofloxacin Related Compound B; Levofloxacin Hemihydrate Impurity F
CAS Registry Number
100986-89-8
Primary record
(3S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (S)-(-)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid; 9,10-Difluoro-3-(S)-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; Levofloxacin Q-acid; Levofloxacin Related Compound B; Levofloxacin Hemihydrate Impurity F
- 库存
- 824 克
- 纯度
- 99.4 %
- CAS
- 100986-89-8
化合物标识与属性
- CAS
- 100986-89-8
- PubChem CID
- 688333
- SMILES
- C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2F)F)C(=O)O
- Canonical SMILES
- C[C@H]1COc2c(F)c(F)cc3c(=O)c(C(=O)O)cn1c23
名称与同义词
- Levofloxacin Q-Acid
- Levofloxacin carboxylic acid
- 100986-89-8
- Levofloxacin acid
- Levofloxacin Q acid
- Levofloxacin related compound B
- Oxygen-fluorine acid
- Ofloxacin Impurity A
- Levofloxacin q-acid, (-)-
- Levofloxacin impurity F
- UNII-08GT8FY84E
- Levofloxacin Impurity A
- Levefluorocarboxylic Acid
- Levofloxacin EP Impurity F
- AC1LELV0
- RefChem:153208
- 08GT8FY84E
- MFCD04039905
- C13H9F2NO4
- Levofloxacin impurity F CRS
- Levofloxacin Q-acid =97%
- (S)-9,10-Difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
- DTXSID60143604
- NVKWWNNJFKZNJO-YFKPBYRVSA-N
- IFLab1_001868
- orb3027198
- SCHEMBL2333806
- DTXCID9066095
- Levofloxacin related compound B
- Levofloxacin related compound B [USP]
- SCHEMBL29872315
- CTK0H4797
- ZINC57096
- CHEBI:167723
- Levofloxacin related compound B RS [USP]
- KS-00000H1D
- ANW-58925
- CID688333
- EBC-58052
- AKOS016002127
- Levofloxacin related compound B (USP)
- AC-7592
- ACN-038327
- FS-4544
- IL24882
- Levofloxacin Q-acid, 98% - 1G 1g
- AJ-09575
- BC209423
- SC-15832
- SY066902
- Levofloxacin related compound B RS (USP)
- AB0088529
- J795.481F
- Levofloxacin Impurity F CRS (Y0002084)
- LEVOFLOXACIN RELATED COMPOUND B [USP-RS]
- CS-0136444
- FT-0602614
- FT-0642442
- L0238
- (2S)-6,7-difluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
- 86D898
- N17092
- 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-, (3S)-
- EN300-1655914
- Levofloxacin Carboxylic Acid (Levofloxacin Difluoro Impurity)
- LEVOFLOXACIN RELATED COMPOUND B (USP-RS)
- LEVOFLOXACIN RELATED COMPOUND B [USP IMPURITY]
- (S)-(-)-910-DIFLRO-23-DIHYD 1G.
- (S)-(-)-910-DIFLRO-23-DIHYD 5G.
- A897275
- F222352
- LEVOFLOXACIN HEMIHYDRATE IMPURITY F [EP IMPURITY]
- (S)-(-)-910-DIFLRO-23-DI 250MG.
- LEVOFLOXACIN RELATED COMPOUND B (USP IMPURITY)
- Q27236408
- (S)-(-)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acid
- 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-, (3S)-
- LEVOFLOXACIN HEMIHYDRATE IMPURITY F (EP IMPURITY)
- Z2681131293
- (3S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
- (S)-(-)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
- Levofloxacin EP Impurity F; USP Levofloxacin Related Compound B
- (-)-9,10-difluoro-3(S)-methyl-7-oxo-2,3-dihydro-7H- pyrido (1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
- (3S)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
- (S)-(-)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido-[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
- (S)-9,10-DIFLUORO-3-METHYL-7-OXO-2,3-DIHYDRO-7H-PYRIDO(1,2,3-DE)(1,4)BENZOXAZINE-6-CARBOXYLIC ACID
- (S)-9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
- 2,6-DICHLORO-4-(3-(1,1-DIMETHYLETHYL)-5-OXAZOLIDINYL)BENZENAMINE
- 82419-35-0
- 8,9-difluoro-3-methyl-6-oxo-2,3-dihydro-6H-1-oxa-3a-azaphenalene-5-carboxylic acid
- Levofloxacin Related Compound B, United States Pharmacopeia (USP) Reference Standard
- (-) -9,10-difluoro-3(S)-methyl-7-oxo-2,3-dihydro-7H -pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
- (-) -9,10-difluoro-3(S)-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
- (-)-9,10-difluoro-3(S)-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
- (-)-9,10-difluoro-3(S)-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
- (2S)-6,7-difluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.0,5,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
- (3S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzooxazine-6-carboxylic acid
- (3S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (S)-(-)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid; 9,10-Difluoro-3-(S)-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; Levofloxacin Q-acid; Levofloxacin Related Compound B; Levofloxacin Hemihydrate Impurity F
- (3S)-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
- (3S)-9,10-Difluoro-2,3-dihydro-3alpha-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
- (3S)-9,10-Difluoro-3-methyl-2,3-dihydro-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzooxazine-6-carboxylic acid
- (3S)-9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-1,4-oxazino[2,3,4-ij]quinoline-6-carboxylic acid
- (S)-(-) 9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4] benzoxazine-6-carboxylic acid
- (S)-(-)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid 97%
- (S)-(-)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 97%
- (S)-(-)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de] [1,4]benzoxazine-6-carboxylic acid
- (S)-(-)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de][1,4]benzoxazine-6-carboxylic acid
- (S)-(-)-9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
- (S)-(-)-9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
- (S)-9,10-Difluro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
- 6,7-diluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
- 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicacid, 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-, (3S)-
- 9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-(3S)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
- 923-011-0